Anti-inflammatory therapy in chronic obstructive pulmonary disease: present and future

Today chronic obstructive pulmonary disease is a major economic and social challenge and the only disease causing an ever-increasing number of fatalities [4, 5]. According to a number of recently completed studies, the prevalence of chronic lung diseases in people aged over 40 years is 10.1 per cent...

Descripció completa

Dades bibliogràfiques

Autor principal:	S. N. Avdeev
Format:	Artigo
Idioma:	Russo
Publicat:	Remedium Group LLC 2013-12-01
Col·lecció:	Медицинский совет
Matèries:	хроническая обструктивная болезнь легких т-лымфоциты мокрота рофлумиласт chronic obstructive pulmonary disease t-lymphocytes sputum roflumilast
Accés en línia:	https://www.med-sovet.pro/jour/article/view/934
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!